Revision as of 22:28, 19 February 2007 editFuzzform (talk | contribs)Extended confirmed users5,784 editsNo edit summary← Previous edit | Revision as of 17:16, 24 February 2007 edit undoBeetstra (talk | contribs)Edit filter managers, Administrators172,045 edits remove 'image = {{PAGENAME}}.png' from drugbox, see template talk:drugbox using AWBNext edit → | ||
Line 1: | Line 1: | ||
{{Drugbox| | {{Drugbox| | ||
|IUPAC_name = ''2-(2-oxopyrrolidin-1-yl)butanamide'' | |IUPAC_name = ''2-(2-oxopyrrolidin-1-yl)butanamide'' | ||
| image= |
| image = Etiracetam.png | ||
| width = 90 | | width = 90 | ||
| CAS_number= | | CAS_number= |
Revision as of 17:16, 24 February 2007
Pharmaceutical compoundFile:Etiracetam.png | |
Clinical data | |
---|---|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.111.445 |
Chemical and physical data | |
Formula | C8H14N2O2 |
Molar mass | 170.209 g/mol g·mol |
3D model (JSmol) | |
SMILES
|
Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active optical form is levetiracetam.
See also
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |